Traditional Chinese medicine combined with peginterferon α-2b in chronic hepatitis B
2025-10-14
(Press-News.org) Background and objectives
Peginterferon-α treatment exhibits low rates of the serological conversion rate of hepatitis B e antigen (HBeAg) and the negative conversion rate of hepatitis B virus (HBV) DNA, with significant myelosuppression leading to treatment discontinuation in some patients. Traditional Chinese medicine (TCM) may ameliorate liver inflammation and modulate immune responses. This study aims to investigate the efficacy of combining TCM with pegylated-interferon (PEG-IFN) α-2b and its impact on myelosuppression adverse effects.
Methods
This study included 117 HBeAg-positive chronic hepatitis B (CHB) patients who started initial antiviral therapy at Xiamen Hospital of TCM between June 2018 and January 2023. According to the treatment regimen, patients were divided into the observation group (n = 56, receiving PEG-IFN α-2b combined with Licorice 15 g, Angelica sinensis 20 g, Poria 20 g, Paeonia lactiflora 20 g, Rhizoma Atractylodis Macrocephalae 20 g, Radix Bupleurum Chinense 20 g, Mentha piperita 3 g, Ginger three slices for more than six months) and the control group (n = 61, receiving PEG-IFN α-2b alone). This study retrospectively analyzed etiological indicators, liver biochemical indicators, and blood routine tests before and after treatment.
Results
After 24 and 48 weeks of treatment, the observation group demonstrated significantly superior outcomes to the control group in quantitative reduction of hepatitis B surface antigen, the serological conversion rate of HBeAg, and the reduction in HBV DNA quantification (P < 0.05). By week 48, the HBV DNA negative conversion rate in the observation group (46.67%) was significantly higher than that in the control group (26.67%) (P < 0.05). Regarding safety, the incidence of myelosuppression in the observation group was significantly lower than that in the control group at both 24 and 48 weeks of treatment (P < 0.05)
Conclusions
Real-world findings demonstrate that adjunctive TCM significantly enhances the antiviral efficacy of peginterferon α-2b in HBeAg-positive CHB patients while concurrently mitigating treatment-limiting myelosuppression. This combination strategy may represent a clinically valuable approach to optimizing interferon-based therapy for CHB.
Full text:
https://www.xiahepublishing.com/2835-6357/FIM-2025-00020
The study was recently published in the Future Integrative Medicine.
Future Integrative Medicine (FIM) is the official scientific journal of the Capital Medical University. It is a prominent new journal that promotes future innovation in medicine.It publishes both basic and clinical research, including but not limited to randomized controlled trials, intervention studies, cohort studies, observational studies, qualitative and mixed method studies, animal studies, and systematic reviews.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-10-14
HOUSTON, October 14, 2025 – The American Pediatric Society (APS) and the Society for Pediatric Research (SPR) are pleased to announce Wendy K. Chung, MD, PhD, as the 2026 Mary Ellen Avery Neonatal Research Award recipient. This award honors a pediatric investigator who has made important contributions to neonatal health through basic or translational research.
Dr. Wendy Chung, MD, PhD, is the Mary Ellen Avery Professor of Pediatrics, Chief of Pediatrics, and Pediatrician-in-Chief at Boston Children’s Hospital and Harvard Medical School. An internationally recognized ...
2025-10-14
The Gabriella Miller Kids First Data Resource Center (Kids First DRC) has launched the Variant Workbench, an innovative tool designed to dramatically accelerate research into childhood diseases.
For researchers studying genetic diseases, this new resource shifts the focus from the complex, time-consuming task of managing massive datasets to the core work of scientific exploration. The Variant Workbench functions as an interactive research environment within the cloud-based CAVATICA platform, essentially serving as a virtual lab bench for discovery.
Previously, ...
2025-10-14
Any life on Mars in the past, present, or future would have to contend with challenging conditions including, among others, shock waves from meteorite impacts and soil perchlorates—highly oxidizing salts that destabilize hydrogen bonds and hydrophobic interactions. Purusharth I. Rajyaguru and colleagues subjected Saccharomyces cerevisiae, which is a widely used model yeast, to shock waves and perchlorates. The authors chose the yeast in part because it has already been studied in space. When stressed, yeast, humans, and many other organisms form ribonucleoprotein ...
2025-10-14
Rechargeable batteries are a fundamental part of today's technological landscape, powering everything from our personal devices to large-scale infrastructure. While many types of rechargeable batteries exist, lithium-ion batteries (LIBs) are by far the most ubiquitous, owing to their outstanding energy density, long life cycle, and low self-discharge rate. However, lithium is rather a scarce element with a very uneven distribution throughout the world, prompting research into batteries made from other materials.
Over the past ...
2025-10-14
As the world strives to achieve carbon neutrality and slow down climate change, hydrogen has emerged as a promising fuel and energy carrier. Producing only water when consumed, hydrogen could help decarbonize industrial processes, power generation, and transportation. However, fulfilling this vision requires massive infrastructure—from high-pressure storage tanks to dedicated pipelines—that must withstand constant material stress due to the nature of hydrogen.
One of the biggest obstacles is hydrogen embrittlement. This is a complex phenomenon where metals, including ...
2025-10-14
GÖTTINGEN, Germany, 14 October 2025 -- Researchers led by Dr. Roberto Goya-Maldonado at the University Medical Center Göttingen have identified a rapid physiological marker that predicts which patients with major depression will respond to magnetic brain stimulation therapy. The peer-reviewed research article, published in Brain Medicine, found that patients whose heart rates slowed within 45 seconds of starting treatment showed significantly greater improvement in depressive symptoms six weeks later.
Uncovering ...
2025-10-14
OXFORD, Oxfordshire, UK, 14 October 2025 -- In a compelling Genomic Press Interview published today in Genomic Psychiatry, Dr. Najaf Amin unveils transformative insights that fundamentally reshape international understanding of depression genetics. The Oxford University Associate Professor, ranked among the top scientists globally in genetics and the top women in science worldwide, shares ground breaking discoveries that promise to revolutionize how researchers across continents approach major depression. With over 350 peer-reviewed publications and an exceptional h-index of 125, Dr. Amin has positioned herself at the vanguard of molecular epidemiology, challenging long-held ...
2025-10-14
CHIBA, JAPAN, 14 October 2025 -- A comprehensive peer-reviewed invited review published today in Psychedelics by Dr. Kenji Hashimoto and colleagues (Dr. Mingming Zhao and Dr. Jianjun Yang) synthesizes the evolving landscape of MDMA-assisted psychotherapy, examining robust clinical evidence in treatment-resistant posttraumatic stress disorder while identifying promising applications in autism spectrum disorder, eating disorders, and existential distress. The review traces the complex journey from early therapeutic promise ...
2025-10-14
CHANGCHUN, Jilin, CHINA, 14 October 2025 -- A peer-reviewed viewpoint article published today in Psychedelics by Prof. Xiaohui Wang and colleagues examines the therapeutic potential of psychedelic substances for treating stress-related psychiatric disorders through novel neurobiological mechanisms. The analysis synthesizes current evidence on how compounds like psilocybin, lysergic acid diethylamide (LSD), and MDMA could fundamentally alter treatment paradigms for depression, anxiety, and posttraumatic stress disorder (PTSD).
Addressing Chronic Stress Impact
The authors emphasize that chronic stress represents a major contributor to psychiatric illness worldwide, with persistent ...
2025-10-14
BELMONT, Massachusetts, USA, 14 October 2025 -- In a compelling Genomic Press Interview published today in Genomic Psychiatry, Dr. Bruce M. Cohen discusses results and insights that are reshaping international approaches to understanding and treating neuropsychiatric disorders. The Robertson-Steele Professor of Psychiatry at Harvard Medical School and Director of the Program for Neuropsychiatric Research at McLean Hospital shares remarkable discoveries from nearly five decades of groundbreaking research and places them in the context of a growing evidence base that can reshape psychiatric practice ...
LAST 30 PRESS RELEASES:
[Press-News.org] Traditional Chinese medicine combined with peginterferon α-2b in chronic hepatitis B
